Keywords: حداقل بیماری باقی مانده; Free light chain; Hevylite; Immunofixation; Minimal residual disease; Pair suppression;
مقالات ISI حداقل بیماری باقی مانده (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: حداقل بیماری باقی مانده; Donor lymphocyte infusion; Allogeneic stem cell transplantation; Multiple myeloma; Graft-versus-host disease; Minimal residual disease;
Keywords: حداقل بیماری باقی مانده; Cancer; Minimal residual disease; Next-Generation sequencing; Low-level single nucleotide variants; Detection; Quantification;
Keywords: حداقل بیماری باقی مانده; Magnetic resonance imaging; Minimal Residual Disease; Multiple Myeloma; Treatment Monitoring; Prognosis; Response Assessment;
Keywords: حداقل بیماری باقی مانده; AML; acute myeloid leukemia; CH; clonal hematopoiesis; CHIP; clonal hematopoiesis of indeterminate potential; FDA; Food and Drug Administration; MDS; myelodysplastic syndrome; MGUS; monoclonal gammopathy of undetermined significance; MRD; minimal residual
Keywords: حداقل بیماری باقی مانده; mass spectrometry; immunoglobulin; multiple myeloma; minimal residual disease;
Keywords: حداقل بیماری باقی مانده; AIHA; autoimmune hemolytic anemia; B2M; β2-microglobulin; BR; bendamustine and rituximab; BTK; Bruton tyrosine kinase; CLL; chronic lymphocytic leukemia; CR; complete remission; FCR; fludarabine; cyclophosphamide; and rituximab; FISH; fluorescence in sit
Keywords: حداقل بیماری باقی مانده; myeloma; flow cytometry; minimal residual disease;
Keywords: حداقل بیماری باقی مانده; Dasatinib; Deep molecular response; Imatinib; Minimal residual disease; Nilotinib;
Keywords: حداقل بیماری باقی مانده; Minimal residual disease; Practice patterns; Acute myeloid leukemia; Prognostication;
Keywords: حداقل بیماری باقی مانده; Acute myeloid leukemia; AML; Response criteria; Minimal residual disease; MRD; Clinical trials;
Keywords: حداقل بیماری باقی مانده; AML; Minimal residual disease; Risk stratification; Stem cell transplantation;
Keywords: حداقل بیماری باقی مانده; ALL; Haploidentical; Relapse; Alternative donors; Conditioning; Minimal residual disease;
Keywords: حداقل بیماری باقی مانده; Minimal residual disease; Donor lymphocyte infusion; Targeted therapy; Acute leukemia; Myelodysplastic syndrome;
Keywords: حداقل بیماری باقی مانده; B-CLPD; B-cell chronic lymphoproliferative disorders; BM; bone marrow; CONT; contaminated group; FCM; flow-cytometry; GC; good-quality group; MGUS; Monoclonal gammopathy of undetermined significance; MM; Multiple myeloma; MRD; minimal residual disease; PB
Keywords: حداقل بیماری باقی مانده; Genetically engineered mouse models (GEMMs); Organoid technology; Multi-omic analysis; Intra-vital microscopy; Minimal residual disease;
Keywords: حداقل بیماری باقی مانده; Acute myeloid leukemia; AML; Autologous transplant; Complete remission; CR; Hematopoietic cell transplantation; HCT; Minimal residual disease; MRD;
Keywords: حداقل بیماری باقی مانده; Acute lymphoblastic leukemia; Minimal residual disease; Follow-up; Repertoire sequencing; Bioinformatics;
Keywords: حداقل بیماری باقی مانده; Acute myeloid leukemia; Allogeneic hematopoietic cell transplantation; Novel conditioning regimens; Minimal residual disease;
Keywords: حداقل بیماری باقی مانده; Multiple myeloma; High-risk cytogenetics; Minimal residual disease; Autologous stem cell transplantation;
Keywords: حداقل بیماری باقی مانده; Allogeneic hematopoietic stem cell transplantation; Myeloid malignancy; Minimal residual disease;
Keywords: حداقل بیماری باقی مانده; Allogeneic hematopoietic stem cell transplantation; Chimerism; Minimal residual disease; Pre-emptive immunotherapy;
Keywords: حداقل بیماری باقی مانده; ABC; advanced breast cancer; CGH; comparative genomic hybridization; CNA; copy number alterations; CTC; circulating tumor cells; ctDNA; cell-free tumor DNA; DEP; dielectrophoretic; DFS; disease-free survival; dPCR; digital PCR; EBC; early breast cancer; E
Keywords: حداقل بیماری باقی مانده; Chronic lymphocytic leukemia; Minimal residual disease; Cell-based diagnostics; Automated gating; Cluster analysis; Flow cytometry; FLOCK;
Keywords: حداقل بیماری باقی مانده; Multicolor flow cytometry; Acute myeloid leukemia; Minimal residual disease;
Keywords: حداقل بیماری باقی مانده; Flow cytometry; Acute myeloid leukemia; Mixed phenotype acute leukemia; Minimal residual disease;
Keywords: حداقل بیماری باقی مانده; Mass cytometry; CyTOF; Flow cytometry; Minimal residual disease; Acute leukemia; Aberrant marker expression;
Keywords: حداقل بیماری باقی مانده; Plasma cell dyscrasia; Plasma cell neoplasm; Multiparametric flow cytometry; Multiple myeloma; Minimal residual disease; MRD; Panel optimization; High-sensitivity assay;
Keywords: حداقل بیماری باقی مانده; Acute leukemia; Minimal residual disease; Flow cytometry; Quantitative PCR;
Keywords: حداقل بیماری باقی مانده; Antibody; Minimal residual disease; Novel therapies; Ph-like signature;
Keywords: حداقل بیماری باقی مانده; Mantle cell lymphoma; Transplantation; Minimal residual disease; Predictors; Survival;
Keywords: حداقل بیماری باقی مانده; Acute lymphoblastic leukemia; ALL; Allogeneic; Cytogenetics; Dasatinib; Imatinib; Minimal residual disease; MRD; Nilotinib; Philadelphia chromosome positive; Ph+; Ponatinib; Stem cell transplant; TKI; Tyrosine kinase inhibitor;
Keywords: حداقل بیماری باقی مانده; Acute myeloid leukemia; Flow cytometry; Relapse; Minimal residual disease; Leucemia aguda mieloblástica; CitometrÃa de flujo; RecaÃda; Enfermedad mÃnima residual;
Keywords: حداقل بیماری باقی مانده; Biomarker; Blood; Circulating tumor cells; Minimal residual disease; Prostate cancer; Prostatectomy;
Keywords: حداقل بیماری باقی مانده; Myeloma; Autologous transplantation; Minimal residual disease;
Keywords: حداقل بیماری باقی مانده; Flow cytometry; Minimal residual disease; Acute myeloid leukaemia; Prognosis
Keywords: حداقل بیماری باقی مانده; Immunophenotype; Minimal residual disease; Multiple myeloma; Sensitivity; Specificity;
Keywords: حداقل بیماری باقی مانده; Multiple myeloma; Stem cell transplantation; Conditioning; Immunotherapy; Minimal residual disease;
Keywords: حداقل بیماری باقی مانده; AA; accelerated approval; ALL; acute lymphoblastic leukemia; CCyR; complete cytogenetic response; CLL; chronic lymphocytic lymphoma; CML; chronic myeloid leukemia; CRC; colorectal carcinoma; CR; complete response; CRi; complete response with incomplete bl
Keywords: حداقل بیماری باقی مانده; Flow cytometry; Myeloma; Plasma cells; MGUS; Minimal residual disease
Keywords: حداقل بیماری باقی مانده; ASCT; autologous stem cell transplant; EMD; extramedullary disease; FLC; free light chain; ISS; International Staging System; KRD; carfilzomib, lenalidomide, and dexamethasone; MGUS; monoclonal gammopathy of undetermined significance; MM; multiple myeloma
Keywords: حداقل بیماری باقی مانده; AE; adverse event; ALL; acute lymphoblastic leukemia; alloSCT; allogeneic hematopoietic stem cell transplant; AYA; adolescent and young adult; BFM; Berlin-Frankfurt-Münster; CAR-T; chimeric antigen receptor-modified T cell; CCyR; complete cytogenetic r
Keywords: حداقل بیماری باقی مانده; Allogeneic stem cell transplantation; Multiple myeloma; Risk status; Minimal residual disease;
Keywords: حداقل بیماری باقی مانده; Canine; Lymphoma; Chemotherapy; Minimal residual disease; Real-time quantitative PCR;
Keywords: حداقل بیماری باقی مانده; MDS; minimal residual disease; minimal identifiable disease; Allogeneic transplantation; Conditioning regimen;
Keywords: حداقل بیماری باقی مانده; Acute lymphoblastic leukemia; Adolescents and young adults; Chimeric antigen receptors; Minimal residual disease; Monoclonal antibodies; Philadelphia chromosome; Tyrosine kinase inhibitors;
Keywords: حداقل بیماری باقی مانده; Cancer stem cell; Chemotherapy; Chemoresistance; Targeted therapy; 5-FU; 5-fluorouracil; ABCT; ATP-binding cassette transporter; ALDH; Aldehyde dehydrogenase; AML; Acute myeloid leukemia; ASC; Adult stem cell; BCRP or ABCG; Breast cancer resistance protei
Keywords: حداقل بیماری باقی مانده; Alemtuzumab; Chronic lymphocytic leukemia; Fludarabine; Minimal residual disease; Small lymphocytic lymphoma
Keywords: حداقل بیماری باقی مانده; Minimal residual disease; MRD acute lymphoblastic leukemia; Flow cytometry; Immunophenotyping
Keywords: حداقل بیماری باقی مانده; Minimal residual disease; Polymerase chain reaction; Acute lymphoblastic leukemia; Leukemia free survival